ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002

In Brief: David Cole Named President of The Medical University of South Carolina

May 9, 2014

Sequestration: $1.71 Billion Cut to NIH Budget Will Reduce Number of RPGs

May 17, 2013

NIH RPG Success Rate to Fall Further

June 7, 2013

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005